VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
192 hedge funds and large institutions have $369M invested in Verve Therapeutics in 2025 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 54 increasing their positions, 64 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 64
17% less capital invested
Capital invested by funds: $444M → $369M (-$74.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
192
Holding in Top 10
1
Calls
$1.09M
Puts
$348K
Top Buyers
| 1 | +$12.6M | |
| 2 | +$4.96M | |
| 3 | +$4.17M | |
| 4 |
Goldman Sachs
New York
|
+$3.07M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$2.74M |
Top Sellers
| 1 | -$8.26M | |
| 2 | -$5.47M | |
| 3 | -$3.96M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$3.64M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.97M |
